Emma Caroline Materne, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Deficiency Syndromes | 1 | 2024 | 557 | 0.700 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 825 | 0.550 |
Why?
|
Cytomegalovirus | 1 | 2020 | 755 | 0.530 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 831 | 0.460 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2163 | 0.370 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 4168 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2151 | 0.310 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4575 | 0.280 |
Why?
|
Azathioprine | 1 | 2023 | 356 | 0.200 |
Why?
|
Dynamin II | 1 | 2019 | 35 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2024 | 1870 | 0.160 |
Why?
|
Rec A Recombinases | 1 | 2018 | 50 | 0.150 |
Why?
|
Immune Evasion | 1 | 2020 | 363 | 0.140 |
Why?
|
Methotrexate | 1 | 2023 | 1720 | 0.140 |
Why?
|
Adenoviruses, Human | 1 | 2018 | 255 | 0.130 |
Why?
|
Adenoviridae Infections | 1 | 2016 | 93 | 0.130 |
Why?
|
Eye Infections, Viral | 1 | 2016 | 60 | 0.130 |
Why?
|
Taq Polymerase | 1 | 2015 | 20 | 0.120 |
Why?
|
Isoleucine | 1 | 2015 | 110 | 0.120 |
Why?
|
Virus Internalization | 1 | 2019 | 496 | 0.120 |
Why?
|
Adenoviridae | 1 | 2019 | 1084 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1351 | 0.110 |
Why?
|
Recombination, Genetic | 1 | 2018 | 1526 | 0.110 |
Why?
|
Leucine | 1 | 2015 | 548 | 0.110 |
Why?
|
Kidney Diseases | 1 | 2024 | 2093 | 0.110 |
Why?
|
Keratitis | 1 | 2016 | 239 | 0.110 |
Why?
|
Cold Temperature | 1 | 2015 | 786 | 0.090 |
Why?
|
Mothers | 1 | 2020 | 2191 | 0.090 |
Why?
|
Peptides | 1 | 2020 | 4338 | 0.080 |
Why?
|
Prevalence | 1 | 2024 | 15698 | 0.070 |
Why?
|
Escherichia coli | 1 | 2018 | 4234 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2016 | 2725 | 0.060 |
Why?
|
Cohort Studies | 1 | 2024 | 41366 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5764 | 0.050 |
Why?
|
Virus Replication | 2 | 2019 | 2435 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26280 | 0.040 |
Why?
|
Female | 3 | 2024 | 391875 | 0.040 |
Why?
|
Middle Aged | 2 | 2024 | 220382 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 29831 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36183 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 59068 | 0.040 |
Why?
|
Treatment Outcome | 1 | 2023 | 64591 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 94 | 0.030 |
Why?
|
Chemokine CXCL1 | 1 | 2016 | 101 | 0.030 |
Why?
|
United States | 1 | 2024 | 72202 | 0.030 |
Why?
|
Humans | 5 | 2024 | 760437 | 0.030 |
Why?
|
Child | 1 | 2024 | 80086 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 88196 | 0.030 |
Why?
|
Male | 2 | 2024 | 360035 | 0.030 |
Why?
|
Cytosol | 1 | 2019 | 888 | 0.030 |
Why?
|
Corneal Stroma | 1 | 2016 | 171 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1610 | 0.030 |
Why?
|
Mutant Proteins | 1 | 2015 | 491 | 0.030 |
Why?
|
Nucleotides | 1 | 2015 | 454 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2015 | 436 | 0.020 |
Why?
|
DNA, Viral | 1 | 2018 | 2201 | 0.020 |
Why?
|
Aged | 1 | 2024 | 168840 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30025 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2015 | 1982 | 0.020 |
Why?
|
Adult | 1 | 2024 | 220781 | 0.020 |
Why?
|
Cornea | 1 | 2016 | 1331 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6377 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9340 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5427 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9533 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7208 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22121 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18216 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81402 | 0.010 |
Why?
|
Animals | 1 | 2016 | 168253 | 0.000 |
Why?
|